In conclusion, our study report novel findings showing that PLA2R1 is repressed in RCC by the loss of VHL tumor suppressor and the activation of the oncogenic HIF2α-c-MYC pathway and that repression favors RCC tumorigenecity. Here, MYC is linked to neoplasm.